NR1H4 and Hepatic fibrosis: Other FXR agonists such as vonafexor and tropifexor have been shown to reduce liver fat content and liver enzyme levels (Ratziu et al., 2023; Anstee et al., 2023), but their effects on liver fibrosis require further verification.